I have carefully read the comments on two articles published by myself in issues 51 and 52 of "Journal of Ultrasonography," concerning the differentiation of the character of solid lesions in the breasts in compression sonoelastography. I would like to thank Dr. Dominique Amy for his perceptive comments to which I shall try to relate.

The application of a proper technique of ultrasound (US) examination and the usage of adequate terminology with respect to the assessed structures is undoubtedly significant. In my own research, I used standard radial technique of breast assessment and the visualized focal lesions were evaluated in two planes.

Bearing in mind the terminology used, I agree that, histologically, there is no such a term as *glandular tissue* and that it indeed is a misnomer. It, however, became so strongly established in the standards of our US examination descriptions and reports that the usage of correct terms: *epithelial and connective tissue* might occur to be incomprehensible. This probably requires changing.

With reference to the further part of the comment concerning the character of lesions categorized to group II (benign lesions), I must say that cystic lesions (anechoic, BIRADS-US 2, cysts) were not included in the examination. Only solid lesions, which manifested the features characteristic of BIRADS-US 3, 4 and 5, were taken into account. However, the microscopic verification revealed that approximately 57% of lesions in group II were fibrocystic. In the majority of cases, these lesions presented themselves as hypoechoic, one was hyperechoic and 14 were isoechoic and were accompanied by additional features characteristic of BIRADS-US 3 and 4.

As far as the third remark is concerned connected with sonoelastography and sonoelastograms, I made every effort to perform the examinations in accordance with the guidelines proposed by the authors of the method (A. Itoh, E. Ueno), bearing in mind the limitations mentioned by Dr. Amy. Sonoelastographic techniques, due to their innovative character, are being continuously perfected. However, in the assessment of focal lesions, particularly those categorized as BIRADS-US 3, compression sonoelastography has already proven to be relevant which is confirmed by the guidelines published in "Ultraschall in der Medizin"/"European Journal of Ultrasound"^([@CIT0001])^.

In the sonoelastograms published in the paper, I presented examples of focal lesions in the breasts with their surrounding structures on the basis of the guidelines published by Itoh and Ueno in "Radiology" in 2006^([@CIT0002])^. The compression level on all five presented sonoelastograms was identical (level 3). The FLR ratio, however, was presented in only one example elastogram for the purposes of illustrating the measurement technique. In both subject groups, FLR ratio was calculated for 94 out of 99 lesions.

The size of lesions in both examined groups was analyzed in greater detail in the author\'s doctoral thesis (defended on 25 October 2012 in Cancer Centre, The Institute of Maria Skłodowska-Curie in Warsaw) -- three measurements were analyzed in two perpendicular planes. The lesions in group I in all dimensions were greater than those in group II in a statistically significant way, which indeed, was only briefly mentioned in the commented publication. Unfortunately, malignant lesions are detected too late in Poland. Similarly, the rate of preinvasive carcinomas found in patients treated in Poland (4.4% in 2009 according to the Polish National Cancer Registry) is lower as compared to other countries of Western Europe or the USA.

With reference to the comments concerning focality and centricity of breast neoplasms, I wish to explain that in group I, several patients manifested multifocal lesions (39 malignancies detected in 30 women). However, this issue was not analyzed in detail.

What is more, in the part of the paper devoted to the discussion about false negative cases in elastograms, it was shown that in the subject group of malignant lesions (group I), there were cases of preinvasive and invasive ductal carcinomas (J Ultrason 2013; 13: 43). There were no cases of colloid (mucinous) carcinomas in the analyzed material. Thus, this type of a neoplasm was not discussed.

I recognize the authority of Dr. Amy in the field of ultrasound assessment of the breasts, including the emphasized importance of having basic knowledge of anatomy as well as of pathophysiology and pathogenesis of breast carcinoma, and I would like to thank for a thorough analysis of my publication. I am particularly grateful for directing my attention to the need for using appropriate terminology both in everyday practice and in academic papers.
